missing translation for 'onlineSavingsMsg'
Learn More
Learn More
STEMCELL Technologies Dasatinib
Description
- Dasatinib is a potent, ATP-competitive tyrosine kinase inhibitor
- It is specific for SRC/ABL kinases, for example, ABL, SRC, LCK, and YES with IC50 values of < 1.0, 0.5, 0.4 and 0.5 nM, respectively, and also demonstrates activity against KIT with an IC50 = 5.0 nM (Lombardo et al.; Davis et al.) Dasatinib is a second-generation inhibitor of the oncogenic tyrosine kinase BCR-ABL with 325-fold more potency than imatinib, and is also able to inhibit imatinib-resistant BCR-ABL mutants (Tokarski et al.) It also inhibits a large number of other kinases (76 of 148 kinases tested) when screened at 10 μM (Carter et al.)
Specifications
Specifications
| CAS | 302962-49-8 |
| Synonym | BMS 354825; Sprycel |
| Quantity | 100 mg |
| Molecular Formula | C22H26ClN7O2S |
| Purity | ≥98% |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?